Citation 1: Stábeli RG, Amui SF, Sant'Ana CD, et al. Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: an example of function versatility of snake venom proteins. Comp Biochem Physiol C Toxicol Pharmacol. 2006;142(3-4):371-381. Published 2006 Mar-Apr. doi:10.1016/j.cbpc.2005.11.020
Citation 2: Soares AM, Rodrigues VM, Homsi-Brandeburgo MI, et al. A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity. Toxicon. 1998;36(3):503-14. Published 1998 Mar. doi:10.1016/s0041-0101(97)00133-5
Citation 3: Watanabe L, Soares AM, Ward RJ, et al. Structural insights for fatty acid binding in a Lys49-phospholipase A2: crystal structure of myotoxin II from Bothrops moojeni complexed with stearic acid. Biochimie. 2005;87(2):161-7. Published 2005 Feb. doi:10.1016/j.biochi.2004.11.005
Citation 4: Salvador GH, Cavalcante WL, Dos Santos JI, et al. Structural and functional studies with mytoxin II from Bothrops moojeni reveal remarkable similarities and differences compared to other catalytically inactive phospholipases Aâ-like. Toxicon. 2013;72:52-63. Published 2013 Sep. doi:10.1016/j.toxicon.2013.06.013
Citation 5: Salvador GH, Dreyer TR, Cavalcante WL, et al. Structural and functional evidence for membrane docking and disruption sites on phospholipase A2-like proteins revealed by complexation with the inhibitor suramin. Acta Crystallogr D Biol Crystallogr. 2015;71(Pt 10):2066-78. Published 2015 Oct. doi:10.1107/S1399004715014443
Citation 6: Salvador GHM, Dos Santos JI, Borges RJ, et al. Structural evidence for a fatty acid-independent myotoxic mechanism for a phospholipase A(2)-like toxin. Biochim Biophys Acta Proteins Proteom. 2018;1866(3):473-481. Published 2018 Mar. doi:10.1016/j.bbapap.2017.12.008
Citation 7: Salvador GHM, Cardoso FF, Gomes AA, et al. Search for efficient inhibitors of myotoxic activity induced by ophidian phospholipase A(2)-like proteins using functional, structural and bioinformatics approaches. Sci Rep. 2019;9(1):510. Published 2019 Jan 24. doi:10.1038/s41598-018-36839-6
Citation 8: Salvador GHM, Gomes AAS, Bryan-Quirós W, et al. Structural basis for phospholipase A(2)-like toxin inhibition by the synthetic compound Varespladib (LY315920). Sci Rep. 2019;9(1):17203. Published 2019 Nov 20. doi:10.1038/s41598-019-53755-5